In order to find the vitreous substitute which can support the retina for a long time and keep the complete structure and residual function. The inventor has proposed the idea of FCVB.
The establishment of company
We have conducted the first trial in the world in Jun,2009.Then we have continually carried out the multi-center clinical trials in the nation.
Finally we completed the selection of multi-center clinical trials in Jul, 2012.
Get the CE verification
We have conducted the official european application in Greece, England, Turky and Belgium.